| Industry Range | | Price / Earnings | N/A | |
| Book Value | 1.34 | |
| Earnings Per Share | -$2.98 | |
| Price To Sales Ratio | 38.87 | |
| Price To Book Ratio | 18.31 | |
| Price To Tangible Book Ratio | 18.31 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 3.9B | |
| Float (MRQ) | 84.29% | |
| Shares Outstanding (MRQ) | 93.8M | |
| Short Interest as a % of Float (MRQ) | 12.53% | |
| Shares Held By Institutions (MRQ) | 101.3M | |
| Industry Range | | Sales | $148.2M | |
| Gross Margin | 94.37% | |
| Net Profit Margin | -190.34% | |
| EBIT Margin | -147.66% | |
| EBITDA Margin | -142.03% | |
| Operating Margins | -147.66% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 7.45 | |
| Quick Ratio (MRQ) | 7.45 | |
| Total Debt/Equity Ratio (MRQ) | N/A | |
| Debt/Common Equity Ratio (MRQ) | N/A | |
| Industry Range | | Return on Equity | -247.73% | |
| Return on Assets | -42.66% | |
| Asset Turnover | 0.22 | |
| Receivables Turnover | 9.54 | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | 2.27% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*CYTK does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.06%